{
    "accession": "ENCBS692PXQ",
    "age": "15",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "EFO:0001187",
    "biosample_term_name": "HepG2",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV29-2)",
    "documents": [
        {
            "attachment": "/documents/05379288-edba-4db6-8930-873efce7628f/@@download/attachment/NT-BGHcLV29-2.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAC",
    "health_status": "hepatocellular carcinoma",
    "lab": "Brenton Graveley, UConn",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "ATCC",
    "summary": "Homo sapiens HepG2 cell line",
    "treatments": []
}